
Apetiz100 ml
Aristopharma Ltd.
FDA-Approved Indications Anorexia, cachexia, or unexplained significant weight loss in patients with acquired immunodeficiency syndrome (AIDS) - Megestrol Acetate oral suspension is approved for the…
Megestrol Acetate is not indicated for the prevention of pregnancy and should never be used as a contraceptive.
| Indication | Recommended Dose of Megestrol Acetate |
|---|---|
| Anorexia, cachexia, or unexplained weight loss in AIDS | Oral suspension: initiate at 400-800 mg/day (10-20 mL); usual effective dose is 800 mg/day (20 mL) once daily |
| Advanced/recurrent/metastatic breast cancer (palliative) | Tablets: 160 mg/day, given as 40 mg four times daily |
| Advanced/recurrent endometrial carcinoma (palliative) | Tablets: 40-320 mg/day in divided doses |
A treatment trial of at least two months with Megestrol Acetate is generally recommended before concluding that treatment has failed to produce a response, particularly for the oncologic indications. See Administration and Duration of Treatment for further guidance.
Patients taking Megestrol Acetate should seek prompt medical attention for symptoms such as leg swelling/pain, sudden shortness of breath, chest pain, or signs of high blood sugar.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.